|
Quotes & Info
|
| ZIOP > SEC Filings for ZIOP > Form 8-K on 13-Mar-2013 | All Recent SEC Filings |
13-Mar-2013
Other Events, Financial Statements and Exhibits
ZIOPHARM Oncology, Inc., or the Company, will present the attached discussion of the Company's palifosfamide development strategy and milestones, as well as the Company's synthetic biology program, at the Barclays Global Healthcare Conference in Miami, Florida, being held on March 13, 2013.
A copy of the above referenced presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K.
(d) Exhibits
Exhibit
No. Description
99.1 Presentation of the Company dated March 13, 2013
|
|